These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18899888)

  • 1. Studies on the complement-fixation reaction in virus systems; equine encephalomyelitis virus antigens and antisera.
    RICE CE
    Cornell Vet; 1947 Oct; 37(4):341-8. PubMed ID: 18899888
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid identification of isolates of Western equine encephalomyelitis virus by the complement-fixation technique.
    FUJIMOTO FY; HOFFMAN MN; LENNETTE EH; OTA MI; WIENER A
    Am J Hyg; 1956 Nov; 64(3):270-5. PubMed ID: 13372520
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of time of contact at 37 C and hydrogen ion concentration on the degree of neutralization of equine encephalomyelitis virus (Eastern type) by immune serum.
    LABZOFFSKY NA
    J Infect Dis; 1946; 79():63-8. PubMed ID: 20996929
    [No Abstract]   [Full Text] [Related]  

  • 4. [STRUCTURE AND MODE OF PROPAGATION OF ANIMAL VIRUS STRAINS. IV. METHODS OF DEMONSTRATION AND EXAMINATION ON THE STRUCTURE OF FOOT-AND-MOUTH-DISEASE VIRUS AND VENEZUELAN EQUINE ENCEPHALITIS VIRUS].
    MUSSGAY M
    Arch Hyg Bakteriol; 1963 Oct; 147():552-76. PubMed ID: 14095153
    [No Abstract]   [Full Text] [Related]  

  • 5. Local immune response and viral growth rate as factors in immunity to equine encephalomyelitis virus.
    SCHLESINGER RW
    Fed Proc; 1949 Sep; 8(3):622-4. PubMed ID: 15391276
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the virus of Venezuelan equine encephalomyelitis. II. Modification by specific immune serum of response of central nervous system of mice.
    BERGE TO; GLEISER CA; GOCHENOUR WS; MIESSE ML; TIGERTT WD
    J Immunol; 1961 Nov; 87():509-17. PubMed ID: 13867629
    [No Abstract]   [Full Text] [Related]  

  • 7. The neutralization of Western equine encephalomyelitis virus by human convalescent serum; the influence of heat labile substances in serum on the neutralization index.
    WHITMAN L
    J Immunol; 1947 Jun; 56(2):97-108. PubMed ID: 20240799
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies of the complement-fixation reaction in virus systems; activities of vaccinia virus antigens and antisera.
    RICE CE
    J Immunol; 1946 Jul; 53(3):225-36. PubMed ID: 20992659
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety and efficacy of an attenuated Venezuelan equine encephalomyelitis vaccine for use in Equidae.
    Spertzel RO; Kahn DE
    J Am Vet Med Assoc; 1971 Sep; 159(6):731-8. PubMed ID: 5158756
    [No Abstract]   [Full Text] [Related]  

  • 10. Eastern equine encephalomyelitis in Massachusetts; report of two cases, diagnosed serologically, with complete clinical recovery.
    DE WEBSTER HF
    N Engl J Med; 1956 Aug; 255(6):267-70. PubMed ID: 13348851
    [No Abstract]   [Full Text] [Related]  

  • 11. AN OUTBREAK OF EASTERN EQUINE ENCEPHALOMYELITIS IN JAMAICA. II. LABORATORY DIAGNOSIS AND PATHOLOGY OF EASTERN EQUINE ENCEPHALOMYELITIS IN JAMAICA.
    BELLE EA; GRANT LS; THORBURN MJ
    Am J Trop Med Hyg; 1964 Mar; 13():335-41. PubMed ID: 14125889
    [No Abstract]   [Full Text] [Related]  

  • 12. A chick embryo-derived complement-fixing antigen for western equine encephalomyelitis.
    HOFFMAN MN; LENNETTE EH; NEFF BJ; WIENER A
    Proc Soc Exp Biol Med; 1956 Jul; 92(3):575-7. PubMed ID: 13359471
    [No Abstract]   [Full Text] [Related]  

  • 13. IMMUNOLOGIC CHARACTERIZATION OF WESTERN EQUINE ENCEPHALOMYELITIS VIRUS STRAINS.
    HENDERSON JR
    J Immunol; 1964 Sep; 93():452-61. PubMed ID: 14218605
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of hyperimmune antiserum concentrates in experimental western equine encephalomyelitis.
    DE BOER CJ; CADILEK AE; WALTERS SR
    J Immunol; 1955 Oct; 75(4):308-14. PubMed ID: 13263596
    [No Abstract]   [Full Text] [Related]  

  • 15. FACTORS INFLUENCING DETERMINATION OF ANTIGENIC RELATIONSHIPS BETWEEN WESTERN EQUINE ENCEPHALOMYELITIS VIRUS STRAINS.
    SATURNO A; HENDERSON JR
    J Immunol; 1965 Mar; 94():365-70. PubMed ID: 14279787
    [No Abstract]   [Full Text] [Related]  

  • 16. Possible occurrence of multiple antigens in type 2 poliomyelitis and GDVII mouse encephalomyelitis viruses.
    RUSTIGIAN R; HAVENS P; KOLNER M
    Proc Soc Exp Biol Med; 1954 Jul; 86(3):500-4. PubMed ID: 13194703
    [No Abstract]   [Full Text] [Related]  

  • 17. [INHIBITION OF THE GROWTH OF THE VENEZUELAN EQUINE ENCEPHALOMYELITIS VIRUS WITH THE USE OF PUROMYCIN].
    ZHDANOV VM; ERSHOV FI
    Antibiotiki; 1965 Mar; 10():255-9. PubMed ID: 14294745
    [No Abstract]   [Full Text] [Related]  

  • 18. Host defenses during primary Venezuelan equine encephalomyelitis virus infection in mice. II. In vitro methods for the measurement and qualitation of the immune response.
    Adler WH; Rabinowitz SG
    J Immunol; 1973 May; 110(5):1354-62. PubMed ID: 4697832
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of in vitro cultivation on the pathogenicity of Venezuelan equine encephalomyelitis virus.
    KOPROWSKI H; LENNETTE EH
    J Exp Med; 1946 Sep; 84():205-10. PubMed ID: 20995219
    [No Abstract]   [Full Text] [Related]  

  • 20. Study of the properties of the virus of Venezuelan equine encephalomyelitis modified by in vitro cultivation in HeLa cells.
    MURPHY LC; BLACKFORD VL; GLEISER CA
    Am J Vet Res; 1955 Oct; 16(61 Part 1):521-4. PubMed ID: 13259028
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.